Once-daily incumbency of LEXIVA plus RTV.

 Once-daily incumbency of LEXIVA plus RTV is not recommended for PI-experienced patients. LEXIVA is the honours PI to effort flexible dosing options with no food or matter restrictions.


Among HIV-positive patients, heartburn, gastroesophageal pathology disease and ulcers are common disorders. A recent looking of 200 HIV-positive patients found that nearly 80 percent of patients have used an OTC acid-reducing agentive role and 39 percent used a written language proton pump inhibitor (PPI). In the period prior to the study, 28 percent reported using an antacid, 25 percent used a prescription medicine PPI and 13 percent used an OTC acid-reducing agentive role including OTC PPIs.


"To avoid potentiality drug interactions, it is important that patients talk with their wellbeing care master about any medications, even over-the-counter products, they are taking," said Mark Shaefer, Pharm. D., acting vice chair, HIV, Infectious Disease Music Maturation Midpoint at GSK. "With this update, patients know that they can take a proton pump inhibitor simultaneously with Lexiva without affecting family tree levels of LEXIVA."